- Develop a detailed commercialisation plan to maximise sales of the P1vital® PReDicT Test across Europe following market launch
- Develop the pricing model for the P1vital® PReDicT Test product based on the cost effectiveness results and stakeholder input
WP3 Lead: Dr Colin Dourish
- WP2 clinical effectiveness, cost effectiveness and clinical utility results from the clinical study will feed into the detailed commercialisation plan.
- WP4 stakeholder engagement activities will feed into the detailed commercialisation plan.